Winslow Asset Management Inc. Purchases 311 Shares of STERIS plc (NYSE:STE)

Winslow Asset Management Inc. raised its holdings in shares of STERIS plc (NYSE:STEFree Report) by 0.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,105 shares of the medical equipment provider’s stock after purchasing an additional 311 shares during the quarter. STERIS makes up approximately 1.5% of Winslow Asset Management Inc.’s portfolio, making the stock its 27th largest holding. Winslow Asset Management Inc.’s holdings in STERIS were worth $7,278,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in STE. Catalyst Capital Advisors LLC purchased a new stake in STERIS during the third quarter valued at about $25,000. VisionPoint Advisory Group LLC bought a new stake in shares of STERIS during the fourth quarter valued at about $34,000. Pingora Partners LLC bought a new stake in shares of STERIS during the fourth quarter valued at about $37,000. Glassman Wealth Services bought a new stake in shares of STERIS during the fourth quarter valued at about $38,000. Finally, Spire Wealth Management increased its position in shares of STERIS by 88.0% during the fourth quarter. Spire Wealth Management now owns 203 shares of the medical equipment provider’s stock valued at $45,000 after buying an additional 95 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on STE. JMP Securities reiterated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Thursday, May 9th. StockNews.com upgraded STERIS from a “hold” rating to a “buy” rating in a research report on Friday, June 7th. Piper Sandler reiterated a “neutral” rating and set a $225.00 price target (up from $220.00) on shares of STERIS in a research report on Friday, May 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Friday, May 10th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $241.60.

Get Our Latest Stock Report on STE

Insider Buying and Selling at STERIS

In other STERIS news, SVP Cary L. Majors sold 2,024 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $232.13, for a total transaction of $469,831.12. Following the transaction, the senior vice president now directly owns 11,369 shares in the company, valued at $2,639,085.97. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, VP Renato Tamaro sold 1,154 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the completion of the sale, the vice president now owns 6,677 shares of the company’s stock, valued at $1,546,660.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Cary L. Majors sold 2,024 shares of the stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $232.13, for a total value of $469,831.12. Following the sale, the senior vice president now directly owns 11,369 shares of the company’s stock, valued at approximately $2,639,085.97. The disclosure for this sale can be found here. Insiders have sold 7,762 shares of company stock worth $1,798,477 over the last ninety days. Insiders own 0.95% of the company’s stock.

STERIS Price Performance

Shares of STE stock traded down $1.37 during trading on Friday, hitting $219.68. The company had a trading volume of 95,513 shares, compared to its average volume of 483,961. The company has a quick ratio of 2.36, a current ratio of 3.08 and a debt-to-equity ratio of 0.49. The stock’s 50-day moving average is $217.52 and its two-hundred day moving average is $219.65. The stock has a market capitalization of $21.73 billion, a price-to-earnings ratio of 57.89 and a beta of 0.85. STERIS plc has a 52 week low of $195.47 and a 52 week high of $254.00.

STERIS (NYSE:STEGet Free Report) last issued its quarterly earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $2.41 by $0.17. STERIS had a net margin of 6.95% and a return on equity of 13.73%. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. During the same period last year, the business earned $2.30 earnings per share. The business’s quarterly revenue was up 10.8% on a year-over-year basis. As a group, analysts predict that STERIS plc will post 9.24 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 12th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date is Wednesday, June 12th. STERIS’s payout ratio is currently 54.45%.

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Read More

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.